Medication Issues Dominate Racing Conference
The Blood-Horse Staff
April 27, 2012
The use and possible abuse of therapeutic medications will be dominating discussions throughout the meeting.
The use and possible abuse of therapeutic medications will be dominating discussions throughout the meeting.
One of the most important causes of embryo loss during early gestation is post-breeding endometritis.
Celebrities and animal welfare group representatives gathered to promote anti-slaughter legislation last week.
This project will evaluate NSAIDs’ effect on a horse’s ability to benefit from a commercial influenza vaccine.
The University of Kentucky Gluck Equine Research Foundation published its 2011 Research Report in late March.
Even the tiniest leg laceration can have dire consequences for nearby tendons if left untreated.
The forum will address marketing initiatives for the equine industry as well as changes in federal advocacy.
An infected horse can show behavioral changes such as drowsiness, depression, fear, or aggression.
Martin Nielsen, DVM, PhD, Dipl. EVPC, and Amanda Adams, PhD, will present at the conference.
The board discussed clenbuterol use in racing, firocoxib thresholds, and other horse health related topics.
I’ll Have Another, a hopeful for the 2012 Kentucky Derby, recently underwent shock wave therapy on his back.
Rule 227(a) prohibits cloned horses or their offspring from being included in the AQHA breed registry.
The recording of TheHorse.com’s Ask the Vet LIVE event on the horse’s upper respiratory tract from April 19
New research indicates horses can slow body processes to conserve energy when environmental factors dictate.
The blaze broke out just after 5 a.m. on April 23. All 19 horses residing in the 20,000 square foot barn died.
The last congressional hearing on horse racing was held in June 2008 and dealt with similar issues.
Stay on top of the most recent Horse Health news with
